• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

    27.52 +0.48 (+1.78%)
    Streaming Delayed Price Updated: 3:37 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 727,489
    Open 27.13
    Bid (Size) 27.50 (12)
    Ask (Size) 27.54 (2)
    Prev. Close 27.04
    Today's Range 26.72 - 27.54
    52wk Range 26.35 - 41.61
    Shares Outstanding 57,031,297
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents an 'Affordable Growth' Opportunity
    Harmony Biosciences (HRMY) offers affordable growth with strong EPS & revenue expansion, a low P/E ratio, and robust profitability in rare neurological treatments. 
    Via Chartmill
    Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (6 Ratings)
    Analysts' ratings for Harmony Biosciences Hldgs (NASDAQ: HRMY) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below... 
    Via Benzinga

    Performance

    YTD
    -21.0%
    -21.0%
    1 Month
    -26.0%
    -26.0%
    3 Month
    -13.6%
    -13.6%
    6 Month
    -17.5%
    -17.5%
    1 Year
    -26.2%
    -26.2%

    More News

    Read More
    Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday
    Via Benzinga
    Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
    Via Stocktwits
    Earnings Scheduled For August 5, 2025
    Via Benzinga
    Harmony Biosciences' Genetic Disorder Drug Disappoints In Phase 3 Study
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Harmony Biosciences Whiffs In 'Undruggable' Genetic Disease; Shares Tumble
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity
    Via Chartmill
    Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Top Affordable Growth Stock
    Via Chartmill
    Harmony Biosciences to Present Rare Epilepsy Data at the 36th International Epilepsy Congress
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity
    Via Chartmill
    Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY): A Prime Affordable Growth Stock with Strong Fundamentals
    Via Chartmill
    Harmony Biosciences Holdings (NASDAQ:HRMY): A Strong Growth Stock with Promising Technical Setup
    Via Chartmill
    Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Value Investment Opportunity with Strong Fundamentals and Growth Potential
    Via Chartmill
    Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025
    From Harmony Biosciences Holdings, Inc.
    Via Business Wire
    Harmony Biosciences Holdings (NASDAQ:HRMY) – A Strong Growth Stock with Attractive Valuation
    Via Chartmill
    Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
    From Harmony Biosciences
    Via Business Wire
    6 Analysts Assess Harmony Biosciences Hldgs: What You Need To Know
    Via Benzinga
    Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
    Via Investor's Business Daily
    Topics Intellectual Property
    HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) – An Undervalued Stock with Strong Fundamentals
    Via Chartmill

    Frequently Asked Questions

    Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
    Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
    Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
    The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
    What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
    The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 27.52
    When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
    The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 09/26/25 03:37 PM ET
    What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
    The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 1.57B
    How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
    Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.